Novel Ionizable Lipid Nanoparticles for SARS‐CoV‐2 Omicron mRNA Delivery
Abstract: mRNA‐based therapy has emerged as the most promising nucleic acid therapy in the fight against COVID‐19. However, a safe and efficacious systemic delivery remains a challenge for mRNA therapy. Lipid nanoparticles (LNPs) are currently widely used in mRNA delivery vehicles. Here, a series of ionizable LNPs is rationally designed. YK009‐LNP is an optimal delivery platform to carry mRNA. YK009‐LNP exhibits higher mRNA delivery efficiency, a more favorable biodistribution pattern, and better safety than the approved MC3‐LNP. In addition, mRNA encoding severe acute respiratory syndrome coronavirus 2 Omicron receptor binding domain protein is synthesized and intramuscular administration of mice with YK009‐LNP‐Omicron mRNA induces a robust immune response and immune protective effect. A novel mRNA delivery vehicle with more powerful delivery efficiency and better safety than the approved LNPs is provided here.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Novel Ionizable Lipid Nanoparticles for SARS‐CoV‐2 Omicron mRNA Delivery ; day:17 ; month:02 ; year:2023 ; extent:14
Advanced healthcare materials ; (17.02.2023) (gesamt 14)
- Urheber
-
Long, Jinrong
Yu, Changxiao
Zhang, Honglei
Cao, Yiming
Sang, Ye
Lu, Haitao
Zhang, Zhen
Wang, Xin
Wang, Huanyu
Song, Gengshen
Yang, Jing
Wang, Shengqi
- DOI
-
10.1002/adhm.202202590
- URN
-
urn:nbn:de:101:1-2023021814104508447577
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Long, Jinrong
- Yu, Changxiao
- Zhang, Honglei
- Cao, Yiming
- Sang, Ye
- Lu, Haitao
- Zhang, Zhen
- Wang, Xin
- Wang, Huanyu
- Song, Gengshen
- Yang, Jing
- Wang, Shengqi